Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16036
Title: Evaluation of non-coding variation in GLUT1 deficiency
Austin Authors: Liu, YC;Lee, JW;Bellows, ST;Mullen, SA;Berkovic, Samuel F ;Bahlo, M;Scheffer, IE;Hildebrand, MS;Clinical, Group
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Department of Medicine, Epilepsy Research Centre, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia
Population Health and Immunity Division, The Walter and Eliza Hall Institute, Parkville, Victoria, Australia
Florey Institute, Heidelberg, Victoria, Australia
Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia
Issue Date: 6-Jun-2016
metadata.dc.date: 2016-06-06
Publication information: Developmental medicine and child neurology, 2016
Abstract: AIM: Loss-of-function mutations in SLC2A1, encoding glucose transporter-1 (GLUT-1), lead to dysfunction of glucose transport across the blood-brain barrier. Ten percent of cases with hypoglycorrhachia (fasting cerebrospinal fluid [CSF] glucose <2.2mmol/L) do not have mutations. We hypothesized that GLUT1 deficiency could be due to non-coding SLC2A1 variants. METHOD: We performed whole exome sequencing of one proband with a GLUT1 phenotype and hypoglycorrhachia negative for SLC2A1 sequencing and copy number variants. We studied a further 55 patients with different epilepsies and low CSF glucose who did not have exonic mutations or copy number variants. We sequenced non-coding promoter and intronic regions. We performed mRNA studies for the recurrent intronic variant. RESULTS: The proband had a de novo splice site mutation five base pairs from the intron-exon boundary. Three of 55 patients had deep intronic SLC2A1 variants, including a recurrent variant in two. The recurrent variant produced less SLC2A1 mRNA transcript. INTERPRETATION: Fasting CSF glucose levels show an age-dependent correlation, which makes the definition of hypoglycorrhachia challenging. Low CSF glucose levels may be associated with pathogenic SLC2A1 mutations including deep intronic SLC2A1 variants. Extending genetic screening to non-coding regions will enable diagnosis of more patients with GLUT1 deficiency, allowing implementation of the ketogenic diet to improve outcomes.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16036
DOI: 10.1111/dmcn.13163
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/27265003
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.